SIM
ITCI

Spark Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Spark Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-199,900
Closed -$3.05M – 897
2016
Q3 		$3.05M Buy
+199,900
New +$8.08M 0.25% 123
2015
Q4 		– Sell
-37,700
Closed -$1.51M – 870
2015
Q3 		$1.51M Buy
+37,700
New +$1.23M 0.2% 164

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spark Investment Management's ITCI Position: Q4 2016 in Review

Spark Investment Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2016, closing a stake of 199,900 shares — an estimated $3.05M sold.

Spark Investment Management first reported a position in ITCI in Q3 2015 and held it in 2 quarters. The position peaked at $3.05M in Q3 2016. 129 funds tracked by Wall St. Rank hold ITCI as of Q4 2016.

  • Spark Investment Management reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2016 after selling out during the quarter.
  • Spark Investment Management sold 199,900 Intra-Cellular Therapies Inc. shares in Q4 2016, an estimated $3.05M.
  • Spark Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 2 quarters.
  • Spark Investment Management's Intra-Cellular Therapies Inc. position peaked at $3.05M in Q3 2016.
  • 129 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.